OrganiGram Interest Expense from 2010 to 2026

OGI Stock  USD 1.29  0.01  0.78%   
OrganiGram Holdings' Interest Expense is increasing with very volatile movements from year to year. Interest Expense is predicted to flatten to about 303.5 K. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2011-12-31
Previous Quarter
65 K
Current Value
52 K
Quarterly Volatility
1.2 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check OrganiGram Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OrganiGram Holdings' main balance sheet or income statement drivers, such as Interest Expense of 303.5 K, Selling General Administrative of 67.4 M or Other Operating Expenses of 301.3 M, as well as many indicators such as Price To Sales Ratio of 2.86, Dividend Yield of 0.0 or PTB Ratio of 0.82. OrganiGram financial statements analysis is a perfect complement when working with OrganiGram Holdings Valuation or Volatility modules.
  
Build AI portfolio with OrganiGram Stock
Check out the analysis of OrganiGram Holdings Correlation against competitors.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
The Interest Expense trend for OrganiGram Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether OrganiGram Holdings is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest OrganiGram Holdings' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of OrganiGram Holdings over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. OrganiGram Holdings' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OrganiGram Holdings' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Very volatile
   Interest Expense   
       Timeline  

OrganiGram Interest Expense Regression Statistics

Arithmetic Mean1,865,454
Geometric Mean0.00
Coefficient Of Variation180.79
Mean Deviation2,502,139
Median277,847
Standard Deviation3,372,506
Sample Variance11.4T
Range10.1M
R-Value0.03
Mean Square Error12.1T
R-Squared0.0008
Significance0.92
Slope18,499
Total Sum of Squares182T

OrganiGram Interest Expense History

2026303.5 K
2025319.5 K
2022277.8 K
2021429 K
2020M
2019M
20189.7 M

About OrganiGram Holdings Financial Statements

Investors use fundamental indicators, such as OrganiGram Holdings' Interest Expense, to determine how well the company is positioned to perform in the future. Although OrganiGram Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Interest Expense319.5 K303.5 K

Currently Active Assets on Macroaxis

When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:
Check out the analysis of OrganiGram Holdings Correlation against competitors.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is there potential for Pharmaceuticals market expansion? Will OrganiGram introduce new products? Factors like these will boost the valuation of OrganiGram Holdings. Anticipated expansion of OrganiGram directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.11
Revenue Per Share
2.105
Quarterly Revenue Growth
0.487
Return On Assets
(0.01)
Return On Equity
0.0464
Investors evaluate OrganiGram Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating OrganiGram Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause OrganiGram Holdings' market price to deviate significantly from intrinsic value.
It's important to distinguish between OrganiGram Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OrganiGram Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, OrganiGram Holdings' market price signifies the transaction level at which participants voluntarily complete trades.